{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:51:47Z","timestamp":1781653907868,"version":"3.54.5"},"reference-count":0,"publisher":"Norwegian Medical Association","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tidsskr Nor Legeforen","Tidsskriftet"],"published-print":{"date-parts":[[2013,4,23]]},"DOI":"10.4045\/tidsskr.13.0410","type":"journal-article","created":{"date-parts":[[2013,4,26]],"date-time":"2013-04-26T03:35:16Z","timestamp":1366947316000},"page":"826-7","source":"Crossref","is-referenced-by-count":1,"title":["Intraven\u00f8s immunglobulinbehandling"],"prefix":"10.4045","volume":"133","author":[{"given":"Susanne Gjeruldsen","family":"Dudman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsti","family":"Vainio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2479","container-title":["Tidsskrift for Den norske legeforening"],"original-title":[],"language":"no","deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:54:08Z","timestamp":1781650448000},"score":1,"resource":{"primary":{"URL":"https:\/\/tidsskriftet.no\/2013\/04\/brev-til-redaktoren\/intravenos-immunglobulinbehandling"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,23]]},"references-count":0,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,4,23]]}},"URL":"https:\/\/doi.org\/10.4045\/tidsskr.13.0410","relation":{},"ISSN":["0029-2001","0807-7096"],"issn-type":[{"value":"0029-2001","type":"print"},{"value":"0807-7096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,23]]}}}